Immune Response News and Research

RSS

Study sheds new light on immune system interactions with cancer

Cancers like melanoma are hard to treat, not least because they have a varied bag of tricks for defeating or evading treatments.

21 Dec 2020

Novel microcopy methods used to study tiny traction forces during T-cell activation

Highly complicated processes constantly take place in our body to keep pathogens in check: The T-cells of our immune system are busy searching for antigens - suspicious molecules that fit exactly into certain receptors of the T-cells like a key into a lock.

21 Dec 2020

Researchers demonstrate potential preventive treatment for Crohn's disease

A potential preventive treatment for Crohn's disease, a form of inflammatory bowel disease, has been demonstrated in a mouse model and using immune-reactive T cells from patients with Crohn's disease.

21 Dec 2020

Many US health experts underestimated the coronavirus … until it was too late

A year ago, while many Americans were finishing their holiday shopping and finalizing travel plans, doctors in Wuhan, China, were battling a mysterious outbreak of pneumonia with no known cause.

21 Dec 2020

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

The onset of the current COVID-19 pandemic revealed the seventh known pathogenic human coronavirus, SARS-CoV-2.

21 Dec 2020

FDA issues first emergency use authorization for second COVID-19 vaccine

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

21 Dec 2020

Study may help explain how COVID-19 increases stroke risk

A UCLA-led study may help explain how COVID-19 increases the risk for stroke. Scientists made the finding by running fluid spiked with a COVID-19-like protein through a 3D-printed model of the arteries of a patient who had suffered a stroke.

18 Dec 2020

Study recommends blinded crossover and continued follow-ups to evaluate SARS-CoV-2 vaccine durability

A new multicenter study has shown that blinded crossover and continued follow-up of trial participants can help assess vaccine durability and potential delayed enhancement of disease.

18 Dec 2020

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Abbott announced today it received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test.

18 Dec 2020

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal.

17 Dec 2020

Antifungal drug improves key biomarkers in the noses of patients with cystic fibrosis

A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study by researchers at the University of Illinois Urbana-Champaign and the University of Iowa found.

17 Dec 2020

MFCR awards new grants to support an emerging approach to cancer therapeutics

The Mark Foundation for Cancer Research has awarded five new grants in support of an important, emerging approach to cancer therapeutics.

17 Dec 2020

Study highlights how the sex differences in COVID-19 are linked to ACE2 protein

Female COVID-19 patients face less severe disease complications and a lower risk of dying than male patients thanks to hormones and chromosomes that contribute to a stronger immune response, according to new research from a University of Alberta-led team.

17 Dec 2020

Immune Response News and Research

Study sheds new light on immune system interactions with cancer

Novel microcopy methods used to study tiny traction forces during T-cell activation

Researchers demonstrate potential preventive treatment for Crohn's disease

Many US health experts underestimated the coronavirus … until it was too late

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

FDA issues first emergency use authorization for second COVID-19 vaccine

Study may help explain how COVID-19 increases stroke risk

Study recommends blinded crossover and continued follow-ups to evaluate SARS-CoV-2 vaccine durability

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Antifungal drug improves key biomarkers in the noses of patients with cystic fibrosis

MFCR awards new grants to support an emerging approach to cancer therapeutics

Study highlights how the sex differences in COVID-19 are linked to ACE2 protein

PVP at Boston Children's awarded $1 million to extend research into adjuvant-based vaccines

Errant DNA triggers immune system response against cancer

SARS-CoV-2 surface proteins alter the expression of key chemokines and cytokines in cell lines

Study shows how melanomas assist T cells from identifying and killing tumor cells

Potency of neutralizing antibodies predicts COVID-19 severity and survival

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News